Patents by Inventor Liang Zeng Yan

Liang Zeng Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLIC PEPTIDE CXCR4 ANTAGONISTS
    Publication number: 20100130409
    Abstract: Provided are lactam-cyclized peptide CXCR4 antagonists useful in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection.
    Type: Application
    Filed: January 25, 2010
    Publication date: May 27, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Wayne David Kohn, Sheng-Bin Peng, Liang Zeng Yan
  • Cyclic peptide CXCR4 antagonists
    Patent number: 7691813
    Abstract: Provided are lactam-cyclized peptide CXCR4 antagonists useful in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection.
    Type: Grant
    Filed: May 20, 2008
    Date of Patent: April 6, 2010
    Assignee: Eli Lilly and Company
    Inventors: Wayne David Kohn, Sheng-Bin Peng, Liang Zeng Yan
  • CYCLIC PEPTIDE CXCR4 ANTAGONISTS
    Publication number: 20080300177
    Abstract: Provided are lactam-cyclized peptide CXCR4 antagonists useful in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection.
    Type: Application
    Filed: May 20, 2008
    Publication date: December 4, 2008
    Inventors: Wayne David Kohn, Sheng-Bin Peng, Liang Zeng Yan
  • Use of trichloroacetimidate linker for peptide synthesis
    Publication number: 20040039161
    Abstract: The present invention provides a solid phase peptide synthetic method for the preparation of C-terminal alchohols, wherein the improvement consists of using trichloroacetimidate as the linker.
    Type: Application
    Filed: August 22, 2002
    Publication date: February 26, 2004
    Inventors: John Philip Mayer, Liang Zeng Yan